Carregant...

FDA’s Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds: Is the Bar Being Set Too High, or Too Low?

FDA draft guidance on 503B compounding widely faulted

Guardat en:
Dades bibliogràfiques
Publicat a:P T
Autor principal: Barlas, Stephen
Format: Artigo
Idioma:Inglês
Publicat: MediMedia USA, Inc. 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218667/
https://ncbi.nlm.nih.gov/pubmed/25395814
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!